Pharmacological treatment of neurobehavioural sequelae of traumatic brain injury

European Journal of Anaesthesiology

Volumn 25, Issue SUPPL. 42, 2008, Pages 131-136

  Lombardi, F ^a  

^a Ospedale S Sebastiano   (Italy)

Author keywords

Brain injury; Cognition disorders; Depression; Long term effects; Psychosis; Trauma

Indexed keywords

AMANTADINE; AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; BUSPIRONE; CITICOLINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; DONEPEZIL; HALOPERIDOL; IDAZOXAN; LITHIUM; METHYLPHENIDATE; NEUROLEPTIC AGENT; PAROXETINE; PHENOXYBENZAMINE; PHENYTOIN; PHYSOSTIGMINE; PINDOLOL; PRAZOSIN; PROPRANOLOL; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; YOHIMBINE; ANTIDEPRESSANT AGENT;

AGGRESSION; COGNITIVE DEFECT; DEPRESSION; DRUG CHOICE; ELECTROSTIMULATION THERAPY; HUMAN; MENTAL DISEASE; NERVE CELL PLASTICITY; NEUROPSYCHOLOGY; PRACTICE GUIDELINE; PSYCHOPHARMACOLOGY; PSYCHOSIS; REVIEW; RISK BENEFIT ANALYSIS; TRAUMATIC BRAIN INJURY; ANIMAL; ARTICLE; BRAIN INJURY; COGNITION; METHODOLOGY; NEUROLOGIC DISEASE; NEUROLOGY; PATHOLOGY; RESTLESSNESS;

AMANTADINE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BRAIN INJURIES; COGNITION; COGNITION DISORDERS; GUIDELINES AS TOPIC; HUMANS; METHYLPHENIDATE; NERVOUS SYSTEM DISEASES; NEUROLOGY; PSYCHOMOTOR AGITATION; SEROTONIN UPTAKE INHIBITORS;

EID: 43149093779     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507003316     Document Type: Review

References (29)

1. Fann JR, Katon WJ, Uomoto JM et al. Psychiatric disorders and functional disability in outpatients with traumatic brain injuries. Am J Psychiatry 1995; 152: 1493-1499.
2. Prigatano GL. Personality disturbances associated with traumatic brain injury. J Consult Clin Psychol 1992; 60: 360-368.
3. Warden DL, Gordon B, McAllister TW et al. Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. Neurobehavioral Guidelines Working Group. J Neurotrauma 2006; 23: 1468-1501.
4. Koponen S, Taiminen T, Portin R et al. Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. Am J Psychiatry 2002; 159: 1315-1321.
5. Gentilini M, Nichelli P, Schoenhuber R. Assessment of attention in mild head injury. In: Levin H, Eisenberg H, Benton A, eds. Mild Head Injury. New York, USA: Oxford University Press, 1989: 163-175.
6. Raskin SA, Mateer CA. Neuropsychological Management of Mild Traumatic Brain Injury. New York, USA: Oxford University Press, 2000.
7. Lezak MD. Neuropsychological Assessment, 3rd edn. New York, USA: Oxford University Press, 1995.
8. McAllister TW. Neuropsychiatric Sequelae of Head Injuries. Psychiatr Clin North Am 1992; 15: 395-413.
9. Wolf AP, Gleckman AD, Cifu DX et al. The prevalence of agitation and brain injury in skilled nursing facilities: a survey. Brain Inj 1996; 10: 241-245.
10. Tateno A, Jorge RE, Robinson RG. Clinical correlates of aggressive behavior after traumatic brain injury. J Neuropsychiatry Clin Neurosci 2003; 15: 155-160.
11. Arciniegas DB, Topkoff J, Silver JM. Neuropsychiatric aspects of traumatic brain injury. Curr Treat Options Neurol 2000; 2: 169-186.
12. Kudoh A, Takase H, Takahira Y, Takazawa T. Postoperative confusion increases in elderly long-term benzodiazepine users. Anesth Analg 2004; 99: 1674-1678.
13. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol 2002; 22: 285-293.
14. Golombok S, Moodley P, Lader M. Cognitive impairment in long-term benzodiazepine users. Psychol Med 1988; 18: 365-374.
15. Stewart SA. The effect of benzodiazepines on cognition. J Clin Psychiatry 2005; 66: 9-13.
16. Mintzer MZ, Griffiths RR. Drugs, memory and metamemory: a dose-effect study with lorazepam and scopolamine. Exp Clin Psychopharmacol 2005; 13: 336-347.
17. Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004; 18: 37-48.
18. Morrens M, Wezenberg E, Verkes RJ et al. Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration. J Clin Psychopharmacol 2007; 27: 15-21.
19. Woodward ND, Purdon SE, Meltzer HY, Zald DH. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizophr Res 2007; 89: 211-224.
20. Meltzer HY, McGurk SR. The effects of clozapine, risperidone and olanzapine on cognitive function in schizophrenia. Schizophr Bull 1999; 25: 233-255.
21. Keefe RS, Seidman LJ, Christensen BK et al. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry 2004; 161: 985-995.
22. Albensi BC, Janigro D. Traumatic brain injury and its effects on synaptic plasticity. Brain Inj 2003; 17: 653-663.
23. Gualtieri CY. Review: pharmacotherapy and neurobehavioural sequelae of traumatic brain injury. Brain Inj 1988; 2: 101-129.
24. Haig AJ, Ruess JM. Recovery from vegetative state of six months duration associated with Sinemet (levodopa/carbidopa). Arch Phys Med Rehabil 1990; 71: 1081-1083.
25. Matsuda W, Sugimoto K, Sato N et al. A cause of primary brain stem injury recovered from persistent vegetative state after L-dopa administration. No To Shinkey 1999; 51: 1071-1074.
26. Feeney DM, Gonzales A, Law WA. Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science 1982; 217: 855-857.
27. Feeney DM, Weisend MP, Kline AE. Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J Neural Transplant Plast 1993; 3: 199-213.
28. Hovda DA, Feeney DM. Amphetamine and experience promote recovery of function after motor cortex injury in the cat. Brain Res 1984; 298: 358-361.
29. Goldstein LB. Pharmacological approach to functional reorganization: the role of norepinephrine. Rev Neurol 1999; 155: 731-736.